• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COVID-19 and diabetes: What does the clinician need to know?新型冠状病毒肺炎与糖尿病:临床医生需要了解什么?
Prim Care Diabetes. 2020 Oct;14(5):558-563. doi: 10.1016/j.pcd.2020.06.010. Epub 2020 Jul 3.
2
Relative Limited Impact of COVID-19 on Diabetes: A Personal View.新冠病毒病对糖尿病的相对有限影响:个人观点
J Diabetes Sci Technol. 2020 Jul;14(4):727-728. doi: 10.1177/1932296820930270. Epub 2020 May 29.
3
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.2019冠状病毒病:糖尿病与心血管疾病管理的考量
J Diabetes Sci Technol. 2020 Jul;14(4):723-724. doi: 10.1177/1932296820930025. Epub 2020 May 30.
4
Estimated Blood Glucose and Hemoglobin A1C in COVID-19: a Preliminary Summarization.2019冠状病毒病中的估计血糖和糖化血红蛋白:初步汇总
Clin Lab. 2020 Sep 1;66(9). doi: 10.7754/Clin.Lab.2020.200421.
5
The Time of Uncertainty in Poland.波兰的不确定时期。
J Diabetes Sci Technol. 2020 Jul;14(4):731-732. doi: 10.1177/1932296820931485. Epub 2020 May 27.
6
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.2019冠状病毒病中的糖尿病:患病率、病理生理学、预后及实际考量
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):303-310. doi: 10.1016/j.dsx.2020.04.004. Epub 2020 Apr 9.
7
COVID-19 Awakens a New Focus on Surge Capacity Blood Glucose Testing and the Critical Role of Telehealth in Self-Management.COVID-19引发了对激增能力血糖检测以及远程医疗在自我管理中的关键作用的新关注。
J Diabetes Sci Technol. 2020 Jul;14(4):733-734. doi: 10.1177/1932296820930035. Epub 2020 Jun 2.
8
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.COVID-19 时代糖尿病患者的心血管风险管理问题。
Diabetes Care. 2020 Jul;43(7):1427-1432. doi: 10.2337/dc20-0941. Epub 2020 May 14.
9
Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.2019冠状病毒病大流行期间的糖尿病:呼吁全球重新与患者建立联系,强调生活方式改变并优化血糖和血压控制。
J Diabetes. 2020 Jul;12(7):556-557. doi: 10.1111/1753-0407.13048.
10
Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?糖尿病与新冠疫情——两种大流行病的交汇:有哪些担忧?
N Z Med J. 2020 May 8;133(1514):85-87.

引用本文的文献

1
Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies.糖尿病与新冠病毒易感性:风险因素及预防和治疗策略
World J Diabetes. 2024 Aug 15;15(8):1663-1671. doi: 10.4239/wjd.v15.i8.1663.
2
Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan.在一家专门的新冠肺炎治疗机构中,接种疫苗的新冠肺炎患者与未接种疫苗的患者的疾病严重程度和结局比较:一项来自巴基斯坦卡拉奇的回顾性队列研究。
Vaccines (Basel). 2023 Jun 30;11(7):1178. doi: 10.3390/vaccines11071178.
3
Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden.瑞典第一至第三波期间 1 型和 2 型糖尿病患者的严重 COVID-19 感染。
Diabetes Care. 2023 Mar 1;46(3):570-578. doi: 10.2337/dc22-1760.
4
COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.2019冠状病毒病与糖尿病:从病理生理学到临床管理
Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.
5
Retrospective study on the impact of COVID-19 lockdown on patients with type 2 diabetes in Northern Jordan.约旦北部 COVID-19 封锁对 2 型糖尿病患者影响的回顾性研究。
BMJ Open. 2022 Nov 8;12(11):e065148. doi: 10.1136/bmjopen-2022-065148.
6
Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities.在2019冠状病毒病大流行期间协助糖尿病患者:审视宗教因素和宗教团体的作用。
World J Clin Cases. 2022 Sep 16;10(26):9180-9191. doi: 10.12998/wjcc.v10.i26.9180.
7
The patient-centered diabetes management during the COVID-19 pandemic.2019冠状病毒病大流行期间以患者为中心的糖尿病管理
Glob Health Med. 2022 Aug 31;4(4):210-215. doi: 10.35772/ghm.2022.01031.
8
Investigation of an acute surge of COVID-19 associated mucormycosis (CAM) cases reported to a tertiary health care institution in Bihar, India.对印度比哈尔邦一家三级医疗机构报告的新冠肺炎相关毛霉菌病(CAM)病例急性激增情况的调查。
J Family Med Prim Care. 2022 Jun;11(6):2802-2810. doi: 10.4103/jfmpc.jfmpc_1909_21. Epub 2022 Jun 30.
9
Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.糖尿病患者感染 COVID-19 的风险增加——病理生理学、治疗和预防方面的当前挑战。
Int J Environ Res Public Health. 2022 May 27;19(11):6555. doi: 10.3390/ijerph19116555.
10
The Second Wave of COVID-19: Clinical Pharmacy Services During a Field Hospital Operation.新型冠状病毒肺炎的第二波疫情:方舱医院运行期间的临床药学服务
Hosp Pharm. 2022 Apr;57(2):205-210. doi: 10.1177/00185787211032361. Epub 2021 Jul 26.

本文引用的文献

1
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.1型糖尿病与2019冠状病毒病:美国一项多中心监测研究的初步结果
Diabetes Care. 2020 Aug;43(8):e83-e85. doi: 10.2337/dc20-1088. Epub 2020 Jun 5.
2
Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.肥胖作为新冠病毒病预后不良的预测因素:一项系统评价。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):655-659. doi: 10.1016/j.dsx.2020.05.020. Epub 2020 May 12.
3
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?COVID-19 影响下的高血糖患者结局:我们能否在血糖控制方面做得更好?
Diabetes Care. 2020 Jul;43(7):1408-1415. doi: 10.2337/dc20-0723. Epub 2020 May 19.
4
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中,严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关,并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.
5
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
6
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.肥胖与 2019 年冠状病毒病严重程度在深圳市某定点医院的相关性研究
Diabetes Care. 2020 Jul;43(7):1392-1398. doi: 10.2337/dc20-0576. Epub 2020 May 14.
7
Remote Glucose Monitoring of Hospitalized, Quarantined Patients With Diabetes and COVID-19.对住院隔离的糖尿病合并新冠病毒肺炎患者进行远程血糖监测
Diabetes Care. 2020 Jul;43(7):e75-e76. doi: 10.2337/dc20-0696. Epub 2020 May 14.
8
Obesity Is a Risk Factor for Greater COVID-19 Severity.肥胖是新冠病毒疾病(COVID-19)病情加重的一个风险因素。
Diabetes Care. 2020 Jul;43(7):e72-e74. doi: 10.2337/dc20-0682. Epub 2020 May 14.
9
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.患有糖尿病和 COVID-19 患者的临床特征和转归与降糖药物的关系。
Diabetes Care. 2020 Jul;43(7):1399-1407. doi: 10.2337/dc20-0660. Epub 2020 May 14.
10
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.COVID-19 患者的糖尿病预防和管理:文献评价。
Diabetologia. 2020 Aug;63(8):1440-1452. doi: 10.1007/s00125-020-05164-x. Epub 2020 May 14.

新型冠状病毒肺炎与糖尿病:临床医生需要了解什么?

COVID-19 and diabetes: What does the clinician need to know?

作者信息

Papadokostaki Eleni, Tentolouris Nikolaos, Liberopoulos Evangelos

机构信息

Department of Medicine, General Hospital of Heraklion Venizeleio-Pananeio, Heraklion, 71409, Greece.

Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.

出版信息

Prim Care Diabetes. 2020 Oct;14(5):558-563. doi: 10.1016/j.pcd.2020.06.010. Epub 2020 Jul 3.

DOI:10.1016/j.pcd.2020.06.010
PMID:32654982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7332931/
Abstract

COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with diabetes and COVID-19.

摘要

新型冠状病毒肺炎(COVID-19)和糖尿病是当前全球的两大流行病。流行病学研究表明,糖尿病是新型冠状病毒肺炎中第二常见的合并症。本综述旨在总结目前关于糖尿病合并新型冠状病毒肺炎患者的患病率、可能的病理生理机制及管理的现有数据。